Volunteers required for CLL research intervie... - CLL Support

CLL Support

22,475 members38,612 posts

Volunteers required for CLL research interviews of relapsed and refractory UK members.

HAIRBEAR_UK profile image
HAIRBEAR_UKFounder Admin
0 Replies

Are you able to take part in a study on Chronic Lymphocytic Leukaemia (CLL) and Mantle Cell

Lymphoma (MCL). Thanks to your help the research company have reached their quota for 'watchful waiting' patients (not currently on treatment).

The researchers are now looking to schedule patients whose condition has relapsed as well as refractory patients (disease did not respond to treatment or returned in less than six months).The researchers are also looking to speak to care givers of this group

This is not a clinical trial,

rather asking patients and carers about their experiences of the various stages

of the disease and treatment.

This may involve face-to-face interviews in central London offices on Monday 21st

of October and also webcam interviews that run on Tuesday 22nd October, Thursday 24th

October and Friday 25th October.

*Pre task - a short homework assignment to be done in preparation for the interview.

Respondents will be required to compile a collage of images or pictures (from any

source) that represent their experience from diagnosis to present.

Rather than post all of the details here, please contact me through a private message and I will provide you with more detail and connect you with the research team.

Nick

CLL Support Association

Written by
HAIRBEAR_UK profile image
HAIRBEAR_UK
Founder Admin
To view profiles and participate in discussions please or .
Read more about...

You may also like...

Time-Limited Triplet Emerges as a Potential Standard in Relapsed/Refractory CLL

residual disease (uMRD) and complete responses (CRs) in patients with relapsed/refractory CLL....

UK Zoom meeting - COVID-19 and shielding update for UK CLL Patients

Marc Auckland, Chair of Trustees at CLL Support and a CLL patient plus a member of this HU...

CAR T was just approved for Relapsed/Refractory CLL/SLL ( Potentially 20% CURE rate)

n-the-fda-approval-of-liso-cel-in-relapsed-refractory-cll-sll

CLL and the NHS in the UK

you need treatment, are all treatment options covered by the NHS (incl. more recent treatments like...

Starting CAR-T therapy for my relapsing CLL

of the CLL Society, I decided it was best to again share details of my personal battle with CLL in...